5-bromo-4-chloro-3-indolyl-?-d-galactopyranoside (x-gal)

Product Description
BioVectra Inc.

-
CA
-
2015On CPHI since
-
500 - 999Employees
Company types
BioVectra Inc.

-
CA
-
2015On CPHI since
-
500 - 999Employees
Company types
More Products from BioVectra Inc. (4)
-
Product Oxidized dithiothreitol (ox dtt)
Biovectra inc offers wide range of pharmaceytical products which includes oxidized dithiothreitol (ox dtt). It belongs to bioprocessing reagents products category. It is useful in optimizing protein folding. Packaging: 10g / 100g / 1kg. -
Product 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (edac-hcl)
Biovectra inc offers wide range of pharmaceytical products which includes 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (edac-hcl). It belongs to bioprocessing reagents products category. It is used to conjugate proteins and polypeptides. Packaging: 25g / 100g / 1kg. -
Product 5-bromo-4-chloro-3-indolyl phosphate, disodium salt (bcip-na)
Biovectra inc offers wide range of pharmaceytical products which includes 5-bromo-4-chloro-3-indolyl phosphate, disodium salt (bcip-na). It belongs to molecular biology reagents products category. It is a substrate for the detection of alkaline phosphatase, frequently in immunodiagnostic applications. Pack... -
Product 5-bromo-4-chloro-3-indolyl phosphate, p-toluidine salt (bcip-t)
Biovectra inc offers wide range of pharmaceytical products which includes 5-bromo-4-chloro-3-indolyl phosphate, p-toluidine salt (bcip-t). It belongs to molecular biology reagents products category. It is a substrate for the detection of alkaline phosphatase, frequently in immunodiagnostic applications. Pa...
BioVectra Inc. resources (3)
-
News BioVectra to build Canada's first mRNA vaccine and biomanufacturing facility
The state-of-the-art centre will be built in Prince Edward Island to support domestic biomanufacturing capabilities -
Whitepaper Enabling Commercial Manufacturing for Highly Complex Small Molecule Drugs through Process Engineering and Technological Innovation
This case study presents the successful collaboration between an early-stage company that was struggling with the development of a realistic and economically viable commercial pathway and BioVectra, a CDMO with 50 years of experience. -
Video BioVectra's CDMO Capabilities
BioVectra offers contract development and manufacturing capacity for intermediates and active pharmaceutical ingredients (APIs) from five North American cGMP facilities. We specialize in Microbial Fermentation, Complex Chemistry, Biologics, and Formulation Development.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance